The Osteoprotegerin/RANK/RANKL system has been implicated in the biological cascade of events initiated by particulate wear debris and bacterial infection resulting in periprosthetic bone loss around loosened total hip arthroplasties (THA). Individual responses to such stimuli may be dictated by genetic variation and we have studied the effect of single nucleotide polymorphisms (SNPs) within these genes. We performed a case control study of the Osteoprotegerin, RANK and RANKL genes for possible association with deep sepsis or aseptic loosening. All patients included in the study were Caucasian and had had a cemented Charnley THA and polyethylene acetabular cup. Cases consisted of 91 patients with early aseptic loosening and 71 patients with microbiological evidence at surgery of deep infection. Controls consisted of 150 THAs that were clinically asymptomatic for over 10 years and demonstrated no radiographic features of aseptic loosening. DNA samples from all individuals were genotyped using Taqman allelic discrimination. The A allele (p<0.001) and homozygous genotype A/A (p<0.001) for the OPG-163 SNP were highly associated with aseptic failure. Additionally, the RANK-575 (C/T SNP) T allele (p=0.004) and T/T genotype (p=0.008) frequencies were associated with aseptic failure. No statistically significant relationship was found between aseptic loosening and the OPG- 245 or OPG-1181 SNPs. When the septic group was compared to controls, the frequency of the A allele (p<0.001) and homozygous genotype A/A (p<0.001) for the OPG-163 SNP were statistically significant. No statistically significant relationship was found between septic failure and the OPG- 245, OPG-1181 or RANK-575 SNPs. Aseptic loosening and possibly deep infection of THA may be under genetic influence to candidate susceptibility genes. SNP markers may serve as predictors of implant survival and aid pharmacogenomic prevention of THA failure.
Patients with a history of septic arthritis or tuberculosis (TB) of the hip frequently develop secondary osteoarthritis (OA). These patients present a challenge for having joint replacement because of abnormal bone development, the possibility of re-infection, soft tissue problems and their life-style (more active than patients with old age arthritis). We retrospectively review a decent group of 55 cases where one stage cemented total hip arthroplasty was performed with history of old hip infection by a team of surgeons at Wrightington Hospital, Lancashire, UK from 1970 to 2008. The purpose of this study is to find the survival analysis with revision (for infection) as the end stage. There are 33 females and 22 males aged from 25 to 75 yrs (mean 52 years). 21 patients had proven or probable tuberculous infection, 29 had the past history of old septic hip, and the remaining 5 had recent septic hip (i.e., less than 5 years). The patients are followed for between 1 to 23 years (mean 10 years). Pre-operatively, 25 patients had arthrodesis while 24 patients had moderate to severe secondary OA. 3 patients had dysplastic acetabulum, 2 patients had shallow acetabulum and 1 had Avascular Necrosis (AVN). In 33 cases, intra-operative tissue samples didn’t grow any organism, 2 samples grew Staphylococcus aureus, 2 samples grew Coagulase Negative Staphylococcus (CNS), 1 grew pseudomonas, samples were not sent in 9 cases, laboratory did not process the sample in 1 case and no documentation found in 3 cases. Cement with antibiotics was used in 45 patients (Gentamicin alone in 37 cases, Gentamicin and Vancomycin in 3 cases, Gentamicin, Fucidic Acid and Eryth-romycin in 2 patients, Gentamicin, Vacncomycin and Streptomycin in 1 patient, Gentamicin and Streptomycin in 1 case and Gentamicin, Vacncomycin and Amoxycillin in 1 patient). Mostly intravenous antibiotics (3 doses of Cefuroxime) were given, but in few cases with old TB, anti-tuberculous treatment was started pre-operatively and continued for 3 months post-op. In 16 patients either antibiotics were not given or not documented to be given. Failure happened in 2 cases of positive intra-op sample culture with Staphylococcus aureus, 1 patient with pre-op aspiration which showed pseudomonas and in 2 cases where tissue sample showed no growth. 8 patients had revision of at least one of the components for aseptic loosening. The 2 failed cases with positive culture with Staphylococcus aureus had post operative antibiotics and extra antibiotics in cement. Both cases had early wound healing issues.
‘Force-closed’, tapered, polished, collar-less stems, (e.g. C-stem, Exeter), are designed to subside in response to expansion of the cement/bone complex over time. Above a certain threshold, distal migration may predict medium-to-long-term failure of ‘shape-closed’ stems. However, no such threshold exists for ‘force-closed’ stems, and these may continue to migrate after 3 years. We believe that the tendency towards stabilisation 2–3 years postoperatively, could be the best predictor of good long-term performance. Twenty OA patients (12F, mean age 66.6 years) were recruited for primary hip replacement with beaded C-stem femoral components. Tantalum marker beads were injected into the proximal femur, and stems were inserted using CMW1 cement and the latest generation cementing technique via a posterior approach: 17, and a lateral, trochanteric approach: 3. RSA X-ray examinations were performed at 1 week, 6 weeks, and at 3, 6, 12, 24 and 36 months postoperatively. The UmRSA system was used to measure and analyse the radiographs. At 36M the mean stem centroid subsidence was 1.05 mm and had levelled off to a low rate. The mean internal rotation of 2.5° at 36M had not significantly changed during the final year (p = 0.08). At 36M the mean posterior migration of the stem centroid was 0.54 mm (rate of 0.11 mm/y) and posterior migration of the femoral head was 1.66 mm (rate of 0.25 mm/y). At 36M the mean subsidence rate was very low and the mean posterior migration was about one third of that reported for another RSA study of the C-stem. Although the mean internal rotation was greater than that reported for the Exeter stem, there was no significant change during the final year. These low rates of migration at 3 years are consistent with the good results found in clinical studies of this femoral component.
Infection in total knee replacement is a devastating complication. Current literature supports two-stage revision as the gold standard treatment. The alternative single stage procedure has been reported to have favourable results. We assessed the early clinical results of single stage revision for infected total knee replacement. Between February 2005 and August 2007, 12 patients had revision total knee replacement for infection by the senior authors at two centres. In the majority of the patients, the infective organism was isolated by arthroscopic synovial biopsy prior to revision. Standard single stage procedure included the explantation, debridement and re-implantation of the prosthesis. All the patients received intravenous antibiotics for six weeks and oral antibiotics were continued for further 6 weeks. All the patients had the inflammatory markers monitored during follow-up. Significant improvement was noted in the SF-12 PCS, WOMAC pain and stiffness scores at the latest follow-up. None of these patients required re-revision. Radiological evaluation was done using the Knee Society system. None of the knees showed evidence of progressive loosening. Radio-opaque lines were found around the stems and were present on immediate post-operative radiographs; this did not indicate loosening or infection at a mean follow-up of two years. Early clinical and radiological results of the single stage revision for infected total knee replacement appear to be promising. One operation, one anaesthetic and quicker recovery are the advantages for the patient and with the reduced hospital stay it is cost-effective. The problems of stiffness in the knee and muscle wasting with cement spacer are avoided.
Above a certain threshold, distal migration may predict medium-to-long-term failure of “shape-closed” (collared, textured) stems. However, no such threshold exists for “force-closed” stems, and these may continue to migrate after 3 years. We believe that the tendency towards stabilisation 2–3 years postoperatively could be the best predictor of good long-term performance.
There have been some concerns in using ceramic bearings, particularly regarding the fracture rate and their subsequent management. Hence, we present here 2 similar cases that highlight the catastrophic failure of metal head when used subsequently to treat the complication of ceramic fractures in Total Hip Arthroplasty (THA).
Both the patients underwent revision THA under the senior author at our tertiary centre-Wrightington Hospital. Intraoperatively near total erosion of the metal head was noted with more than one litre of black, dense material collection in and around the hip joint revealing extensive metallosis. The acetabular cup was grossly loose and significant loss of bone stock was noted due to metallosis. Single stage revision surgery was performed with impaction bone grafting for deficient acetabulum and cemented components were used. At one-year follow-up none of the cases have shown any further wear or complications.
None of the 4558 stems have been revised for aseptic loosening or fracture. The patient’s mean age at surgery was 48 years (range 15–76), and 171 hips with a mean follow-up of 11 years (range 10–13.7) have now passed 10 years. There were 97 females and 64 males in this group with 10 patients having bilateral C-stems. The main underlying pathologies were Primary Osteoarthritis 30%, Developmental Dysplasia of the hip 27% and Avascular Necrosis of the hip 19%. Clinical outcome graded according to d’aubigne and postel for pain, function and movement has improved from 3.1, 3.1 and 2.9 to 5.9, 5.7 and 5.6 respectively. A good quality proximal femur had been maintained in 47.1% and improved in a further 29.9%.
Introduction: Revision arthroplasty using the impaction grafting technique is an increasingly popular technique. The lost bone stock is replaced rather than substituted with ever increasing amounts of metal. There have been many advances in the understanding of this technique in recent years. It has recently been shown that washing of the graft improves the biomechanical strength, bony ingrowth and biocompatibility of morsellised allograft bone. The aim of this study was to identify the most efficacious method of washing morsellised allograft in the operating room.
Hip arthroplasty has its true genesis in 1962 when the Charnley Total Hip was first implanted. The system comprised a stainless steel femoral stem with fixed 22,225mm head articulating against an all polyethylene acetabular cup. Both components were fixed in position with acrylic bone cement. There have been a number of changes in design, materials and surgical technique but the essential concept remains the same. The system was widely used by both senior and junior surgeons. Numerically implantations peaked at ~45,000 per annum in the late1980’s and is still at around ~25,000 per annum in the mid 2000’s. Geographically the system was used in all five continents. Patients varied widely both in age, activity, and diagnosis. It would therefore seem an appropriate vehicle to examine the variations in results of total hip replacement by patient profile, geography, and era of implantation. A search was carried out on the US NCBI website for publications reporting on results with the Charnley system up to the end of 2002, and which comprised a follow-up of more than 10 years, and gave survivorship data. This resulted in 28 papers with 14 countries of origin available for review. For all studies basic data such as age and diagnosis, range implantation dates, likely specific design of prosthesis, origin of study and number in study was either reported or could be deduced. A ten year survivorship was reported in 16 studies for stem and cup and 7 for stem only. If the longest follow-up was considered for each study then 18 reported on stem and cup (9392 hips, implanted 1962–92) and 15 on stem only (4243 hips, implanted 1966–91). A total of 11 studies had four of more points on a survivorship curve, seven with stem and cup, four with stem only. There are a number of points of interest in this data. The first is that with one exception the performance is remarkably consistent as shown by the survivorship curves. There is no significant difference in the survival rates from different centres, countries, and with implantation dates ranging from 1962 through to 1992. Secondly, there appears to have been little or no change in the average age of patients with implant date. There is some evidence to indicate from the 10 year data that failure rate per year is lower in older patients but does not seem to be affected by implantation date. The latter despite the fact that both surgical technique and component design changed over the 30 year implantation period. A further observation is that the failure rate per year is lower in studies with greater numbers of patients. The general conclusion from this review is that the Charnley Total Hip is remarkably consistent in its performance both over time and location of implantation. Its performance also seems to have been affected very little by changes in technique or design.
The Triple-tapered cemented polished C-Stem has evolved from the study of long-term results of the Charnley low-frictional torque arthroplasty when the first fractured stem and then proximal strain shielding of the femur and stem loosening were identified as the continuation of the same process- the lack or loss of proximal stem support. The concept, design and the surgical technique cater for a limited slip of the C-stem within the cement mantle transferring the load more proximally. With a follow-up past 12 years and 4063 primary procedures there have been no revisions for aseptic stem loosening and no stem is radiologically loose. We have reviewed 1008 primary C-Stem hip arthroplasties performed by 23 surgeons with a minimum of 5 years clinical and radiological follow-up. The mean follow-up was 7 years (range, 5 – 12) and the mean age at surgery was 57 years (range (15 – 85). In 58% the underlying pathology was primary osteoarthritis, 20% congenital dysplasia, 10% quadrantic head necrosis, 5% rheumatoid arthritis, 5% slipped upper femoral epiphysis and 4% protrusio acetabulae. The concept of the triple tapered stem is validated radiologically with an improved proximal femoral bone stock in over 20% of cases and a maintained bone stock in 60%. There were no post-operative complications within 1 year in 87% and no late complications (after 1 year) in 91%. The main late complications were 3.9% aseptic cup loosening, 1% infection and 0.8% dislocation. There were no aseptic loose stems. Twenty-eight hips have been revised (2.8%), 3 for infection, 2 for dislocation and 23 for aseptic cup loosening. There were no revisions for aseptic stem loosening. The results support the concept but place a demand on the understanding of the technique and its execution at surgery.
Impaction grafting with morsellised allograft is becoming the treatment of choice for revision arthroplasty, especially in the younger patient. The optimum treatment of the graft prior to impaction has not been determined. Some groups wash the graft prior to impaction and others do not. Washing of graft has been shown to enhance bone ingrowth in an animal model, however the reasons for this remain unclear. The aim of this study was to identify any underlying cellular cytotoxicty of fresh frozen allograft bone before and after washing. Paired samples of washed and unwashed morcellised FFH allograft were taken during revision hip arthroplasties. Washing was performed by 4 consecutive rinses in 300ml warmed saline, the bone being filtered between each exchange of saline. Contact cytotoxicity assays involved culture of cell lines in direct contact with bone samples. Quantitative cytotoxicity assays utilised culture media conditioned with the bone samples and subsequent assessment of cell metabolism and viability using both dimethylthiazol (MTT) and neutral red (NR) assays. Assays were performed with human osteoblastic (MG63) and fibroblastic (HSF) cell lines. Nine pairs of samples were analysed. Contact assays demonstrated a clear zone of cellular inhibition around the unwashed bone samples. Quantitative assays were performed in triplicate for each cell type and both MTT and NR assays giving 108 paired assay results. 88.9% of pairs (92/108) showed cytotoxicity in the unwashed sample. No washed samples demonstrated cytotoxicity. When grouped by assay and cell type, analysis of means showed statistically significant differences between washed and unwashed samples in MG63-NR (p=0.0025), HSF-NR (p=0.0004) and MG63-MTT (p=0.008). The difference observed in the HSF-MTT assays did not reach statistical significance (p=0.06). Unwashed FFH allograft can be cytotoxic to human osteoblastic and fibroblastic cell lines in vitro. This suggests that allograft should be washed prior to impaction in order to optimise the biological compatibility.
These results provide a biochemical insight into the bone formation and bone resorption processes during allograft incorporation.
The mean Haemoglobin of the reinfused blood in the hip group was 6.9 gm/dl significantly lower (p<
0.05) than the drained blood Hb. of 10.9. Similarly the Haemoglobin of the blood reinfused in knee replacements was significantly lower at 6.8 gm/dl. (p<
0.001). This was less than half of the average Hb. content of homologous blood transfusion.
The mean Haemoglobin of the reinfused blood in the hip group was 6.9 gm/dl significantly lower (p<
0.05) than the drained blood Hb. of 10.9. Similarly the Haemoglobin of the blood reinfused in knee replacements was significantly lower at 6.8 gm/dl. (p<
0.001). This was less than half of the average Hb. content of homologous blood transfusion
Fresh frozen femoral head (FFH) allograft is commonly used in impaction grafting for revision hip arthroplasty and long term success has been demonstrated by some groups. The optimum treatment of the graft prior to impaction has not yet been determined. Some groups wash the graft prior to impaction and others do not. Washing of the graft has been shown to improve bone ingrowth in a bone chamber animal model however the reasons for this remain unclear. The aim of this study was to identify any underlying cellular cytotoxicty of fresh frozen allograft bone before and after washing. Samples of morcellised FFH allograft were taken during revision hip arthroplasties prior to impaction grafting. Paired samples, taken before and after washing were taken from each case. Washing was performed by 4 consecutive washes in 300ml warmed saline, the bone being filtered between each exchange of saline. Cytotox-icity was assessed for all samples using both contact and extract assays. Contact assays involved culture of cell lines in direct contact with bone samples. Extract assays utilised culture media conditioned with bone samples and subsequent quantitative assessment of cell metabolism and viability using both dimethylthiazol (MTT) and neutral red (NR) assays. All assays were performed using both human osteoblastic (MG63) and fibroblastic (HSF) cell lines. Nine pairs of samples were analysed for cytotoxicity using both cell lines. Contact assays demonstrated a clear zone of cellular inhibition around the unwashed bone samples. Extract assays were performed in triplicate for each cell type and both MTT and NR assays giving 108 paired assay results. 88.9% of pairs (92/108) showed cytotoxicity in the unwashed sample. No washed samples demonstrated cytotoxicity. When grouped by assay and cell type, analysis of means showed statistically significant differences between washed and unwashed samples in MG63-NR (p=0.0025), HSF-NR (p=0.0004) and MG63-MTT (p=0.008). The difference observed in the HSF-MTT assays did not reach statistical signifi-cance (p=0.06). In conclusion, we have shown that unwashed FFH allograft can be cytotoxic to human osteoblastic and fibroblastic cell lines in vitro. This suggests that allograft should be washed prior to impaction in order to optimise the biological compatibility.